|
Report Date : |
20.06.2013 |
IDENTIFICATION DETAILS
|
Name : |
SCETI KK |
|
|
|
|
Registered Office : |
DF Kasumigaseki Place 4F, 3-6-7
Kasumigaseki Chiyodaku Tokyo 100-0013 |
|
|
|
|
Country : |
Japan |
|
|
|
|
Financials (as on) : |
31.12.2012 |
|
|
|
|
Date of Incorporation : |
Nov 2005 |
|
|
|
|
Com. Reg. No.: |
0100-01-096581 (Tokyo-Chiyodaku) |
|
|
|
|
Legal Form : |
Limited Company |
|
|
|
|
Line of Business : |
Import, export, wholesale of medicine, food ingredients,
cosmetic ingredients |
|
|
|
|
No. of Employees : |
57 |
RATING & COMMENTS
|
MIRA’s Rating : |
B |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
26-40 |
B |
Capability to overcome financial difficulties seems
comparatively below average. |
Small |
|
Maximum Credit Limit : |
YEN 143.8 MILLION |
|
Status : |
Moderate |
|
Payment Behaviour : |
Regular |
|
Litigation : |
--- |
NOTES
:
Any query related to this report
can be made on e-mail: infodept@mirainform.com while quoting report
number, name and date.
ECGC Country Risk Classification List – March 31st,
2013
|
Country Name |
Previous Rating (31.12.2012) |
Current Rating (31.03.2013) |
|
Japan |
A1 |
A1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
JAPAN - ECONOMIC OVERVIEW
In the years following World War II, government-industry cooperation, a strong work ethic, mastery of high technology, and a comparatively small defense allocation (1% of GDP) helped Japan develop a technologically advanced economy. Two notable characteristics of the post-war economy were the close interlocking structures of manufacturers, suppliers, and distributors, known as keiretsu, and the guarantee of lifetime employment for a substantial portion of the urban labor force. Both features are now eroding under the dual pressures of global competition and domestic demographic change. Japan''s industrial sector is heavily dependent on imported raw materials and fuels. A small agricultural sector is highly subsidized and protected, with crop yields among the highest in the world. While self-sufficient in rice production, Japan imports about 60% of its food on a caloric basis. For three decades, overall real economic growth had been spectacular - a 10% average in the 1960s, a 5% average in the 1970s, and a 4% average in the 1980s. Growth slowed markedly in the 1990s, averaging just 1.7%, largely because of the after effects of inefficient investment and an asset price bubble in the late 1980s that required a protracted period of time for firms to reduce excess debt, capital, and labor. Modest economic growth continued after 2000, but the economy has fallen into recession three times since 2008. A sharp downturn in business investment and global demand for Japan''s exports in late 2008 pushed Japan into recession. Government stimulus spending helped the economy recover in late 2009 and 2010, but the economy contracted again in 2011 as the massive 9.0 magnitude earthquake and the ensuing tsunami in March disrupted manufacturing. The economy has largely recovered in the two years since the disaster, but reconstruction in the Tohoku region has been uneven. Newly-elected Prime Minister Shinzo ABE has declared the economy his government''s top priority; he has pledged to reconsider his predecessor''s plan to permanently close nuclear power plants and is pursuing an economic revitalization agenda of fiscal stimulus and regulatory reform and has said he will press the Bank of Japan to loosen monetary policy. Measured on a purchasing power parity (PPP) basis that adjusts for price differences, Japan in 2012 stood as the fourth-largest economy in the world after second-place China, which surpassed Japan in 2001, and third-place India, which edged out Japan in 2012. The new government will continue a longstanding debate on restructuring the economy and reining in Japan''s huge government debt, which exceeds 200% of GDP. Persistent deflation, reliance on exports to drive growth, and an aging and shrinking population are other major long-term challenges for the economy.
|
Source : CIA |
SCETI KK
Sceti KK
DF Kasumigaseki
Place 4F, 3-6-7 Kasumigaseki Chiyodaku Tokyo 100-0013
JAPAN
Tel:
03-5510-2662
Fax: 03-5510-0134
E-Mail
address: medical@sceti.co.jp
Import,
export, wholesale of medicine, food ingredients, cosmetic ingredients, etc
Nil
Asia
FABIEN
REYJAL, PRES
Tohru Umezu, dir
Masayoshi
Katsuta, dir
Yen
Amount: In million Yen, unless
otherwise stated
FINANCES FAIR A/SALES Yen 3,092 M
PAYMENTS REGULAR CAPITAL Yen
150 M
TREND SLOW WORTH Yen
1,404 M
STARTED 2005 EMPLOYES 57
TRADING FIRM SPECIALIZING IN MEDICINES, FOOD INGREDIENTS,
COSMETIC INGREDIENTS, OTHER.
FINANCIAL SITUATION CONSIDERED
FAIR AND GOOD FOR ORDINARY BUSINESS ENGAGEMENTS.
MAX
CREDIT LIMIT: YEN 143.8 MILLION, 30 DAYS NORMAL TERMS
The subject company was established originally in 1952 as
part of DF Group, as Sceti Co Ltd, and on 01/01/2006 was transferred to Sceti
KK, as captioned. This is a trading firm
for import, export and wholesale of nuclear medicines, food ingredients, cosmetics
ingredients, other (See OPERATION). Clients include pharmaceutical makers,
cosmetics makers, other
The sales volume for Dec/2012 fiscal term amounted to Yen
3,092 million, a 37% down from Yen 4,934 million in the previous term. Large lot orders were received for medical
instruments & devices for the last term, as reported. The recurring profit was posted at Yen 727
million and the net profit at Yen 442 million, respectively, compared with Yen
786 million recurring profit and Yen 405 million net profit, respectively, a
year ago.
For the current term ending Dec 2013 the recurring profit is
projected at Yen 730 million and the net profit at Yen 450 million,
respectively, on a 4% rise in turnover, to Yen 3,200 million.
The financial situation is considered FAIR and good for
ORDINARY business engagements. Max
credit limit is estimated at Yen 143.8 million, on 30 days normal terms.
Date Registered: Nov
2005
Regd No.: 0100-01-096581
(Tokyo-Chiyodaku)
Legal Status: Limited Company (Kabushiki Kaisha)
Authorized: 3,000 shares
Issued:
3,000 shares
Sum: Yen
150 million
Major shareholders (%): Denis Japan SA (100)
Nothing
detrimental is known as to the commercial morality of executives.
Activities: Imports, exports and wholesales
reagents, nuclear medicine, medical devices, food ingredients, cosmetics
ingredients, other (--100%)
(Handling Items by Divisions):
Medical Science: nuclear medicines, medical devices,
research reagents, sterilization solution, other;
Life & Food Science: functional food ingredients,
food ingredients, nutritional ingredients, bio chemical, other;
Beauty Science: cosmetic ingredients, other
Clients: [Mfrs, wholesalers] Japan Radioisotope
Assn, Nakalai Tesque Inc, L S Factory, Terumo Corp, Fukuda Denshi, Asahi Food
& Healthcare, Nipro Corp, Kimura Sangyo Co, Nakarai Tesque Co, other
No. of
accounts: 300
Domestic
areas of activities: Nationwide
Suppliers: [Mfrs, wholesalers] Iba, Grow Co,
Luminous, Leiber, ABX, Silab, other
Domestically: Merck Japan,
Mitsubishi Chemical Medience Corp, Yanaihara Institute Inc, other.
Payment record: Regular
Location:
Business area in Tokyo. Office premises
at the caption address are leased and maintained satisfactorily.
Bank References:
MUFG
(Aoyamadori)
SMBC
(Aoyama)
Relations:
Satisfactory
(In Million Yen)
|
Terms Ending: |
31/12/2013 |
31/12/2012 |
31/12/2011 |
31/12/2010 |
|
|
Annual
Sales |
|
3,200 |
3,092 |
4,934 |
2,447 |
|
Recur.
Profit |
|
730 |
727 |
786 |
737 |
|
Net
Profit |
|
450 |
442 |
405 |
151 |
|
Total
Assets |
|
|
1,823 |
2,323 |
3,690 |
|
Current
Assets |
|
|
1,486 |
1,952 |
|
|
Current
Liabs |
|
|
419 |
1,362 |
|
|
Net
Worth |
|
|
1,404 |
961 |
555 |
|
Capital,
Paid-Up |
|
|
150 |
150 |
150 |
|
Div.P.Share(¥) |
|
|
0.00 |
0.00 |
0.00 |
|
<Analytical Data> |
(%) |
(%) |
(%) |
(%) |
|
|
S.Growth Rate |
3.49 |
-37.33 |
101.63 |
-42.73 |
|
|
Current Ratio |
|
.. |
354.65 |
143.32 |
.. |
|
N.Worth Ratio |
.. |
77.02 |
41.37 |
15.04 |
|
|
R.Profit/Sales |
|
22.81 |
23.51 |
15.93 |
30.12 |
|
N.Profit/Sales |
14.06 |
14.29 |
8.21 |
6.17 |
|
|
Return On Equity |
.. |
31.48 |
42.14 |
27.21 |
|
Notes:
Forecast (or estimated) figures for the 31/12/2013 fiscal term.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian
Rupees |
|
US Dollar |
1 |
Rs.58.74 |
|
UK Pound |
1 |
Rs.91.98 |
|
Euro |
1 |
Rs.78.69 |
INFORMATION DETAILS
|
Report
Prepared by : |
NLM |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for
credit transaction. It has above average (strong) capability for payment of
interest and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy.
General unfavourable factors will not cause fatal effect. Satisfactory
capability for payment of interest and principal sums |
Fairly
Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet
normal commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems
comparatively below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and
principal sums in default or expected to be in default upon maturity |
Limited
with full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be
exercised |
Credit
not recommended |
|
-- |
NB |
New
Business |
-- |
This score serves as a reference to assess SC’s
credit risk and to set the amount of credit to be extended. It is calculated
from a composite of weighted scores obtained from each of the major sections of
this report. The assessed factors and their relative weights (as indicated
through %) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit
history (10%) Market
trend (10%) Operational
size (10%)
This report is issued at your request without any risk
and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its
officials.